Trial Profile
Growth Hormone or Sildenafil as Therapies for Fatigue in MTBI
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Sildenafil (Primary) ; Somatropin (Primary)
- Indications Somatotropin deficiency; Traumatic brain injuries
- Focus Therapeutic Use
- 01 Feb 2018 Status changed from active, no longer recruiting to completed.
- 26 Oct 2016 Status changed from recruiting to active, no longer recruiting.
- 15 Jul 2016 Planned primary completion date changed from 1 Jun 2017 to 1 Dec 2017.